Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Measurement of retinal nerve fiber layer thickness in eyes with optic disc swelling by using scanning laser polarimetry and optical coherence tomography.
Evolution of rapid nerve conduction.
Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.
Does ability to walk reflect general functionality in inflammatory neuropathies?
CNS accumulation of regulatory B cells is VLA-4-dependent.
The economic impact of multiple sclerosis in Australia in 2010.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.
Matrix metalloproteinase-7, matrix metalloproteinase-9, and disease activity in pediatric multiple sclerosis.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Diminished schwann cell repair responses underlie age-associated impaired axonal regeneration.
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
[TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS].
[Anesthetic Management of Three Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier.
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography tandem mass spectrometry.
Therapeutic management of severe relapses in multiple sclerosis.
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.

Pages